Study Comparing the Efficacy of 2 RIC Regimens (Clofarabine vs Fludarabine) in Adults With AML Eligible to Allo-SCT
A phase 2 trial of Fludarabine, Busulfan and Clofarabine in Acute myeloid leukaemia, run by Nantes University Hospital, now recruiting.
Overview
Study Comparing the Efficacy of 2 RIC Regimens (Clofarabine vs Fludarabine) in Adults With AML Eligible to Allo-SCT is a phase 2 interventional study registered as NCT05917405 by Nantes University Hospital, with 302 participants planned, started 2023-09-14 and due to reach its primary completion in 2028-09-14. Interventions recorded: Fludarabine, Busulfan, ATG, Clofarabine. Conditions recorded: Acute Myeloid Leukemia in Remission.
Linked to the drug Clofarabine because the registry names it among its interventions and Acute myeloid leukaemia among its conditions. Registry record only: no result has been read by an editor.
Similar pages
not linked directly; found by shared links- TrialClofarabine Plus Cytarabine Versus Conventional Induction Therapy And A Study Of NK Cell Transplantation In Newly Diagnosed Acute Myeloid Leukemia
Shares Clofarabine, Acute myeloid leukaemia and the tag pipeline.
- TrialClinical Phase III Trial Treosulfan-based Conditioning Versus Reduced-intensity Conditioning (RIC)
Shares Busulfan, Acute myeloid leukaemia and the tag pipeline.
- TrialClinical Study of ARD103 CAR-T Therapy for Patients With R/R AML or MDS
Shares Fludarabine, Acute myeloid leukaemia and the tag pipeline.
- TrialBiomarker-Guided Dual-Target CAR-T Cells for Advanced Solid Tumors
Shares Fludarabine and the tag pipeline.
- TrialDual-Target GD2/B7-H3 CAR-NK Cells for Pediatric Relapsed or Refractory Neuroblastoma
Shares Fludarabine and the tag pipeline.
- TrialPanobinostat, Gemcitabine Hydrochloride, Busulfan, and Melphalan Before Stem Cell Transplant in Treating Patients With Refractory or Relapsed Multiple Myeloma
Shares Busulfan and the tag pipeline.
- TrialA Study of ASP2215 Versus Salvage Chemotherapy In Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML) With FMS-like Tyrosine Kinase 3 (FLT3) Mutation
Shares Fludarabine, Acute myeloid leukaemia and the tag pipeline.
- TrialDual-target CLDN18.2/HER2 CAR-NK Cells for Advanced Gastric/GEJ Cancer
Shares Fludarabine and the tag pipeline.